Introducing Our Speakers

Mohamed Abdel-Hady, Pharmacovigilance And Epidemiology Manager, Gilead Sciences

Mohamed Abdel-Hady | Pharmacovigilance And Epidemiology Manager | Gilead Sciences » speaking at Drug Safety Congress

Anupam Agarwal, Vice President Global Head Of Drug Safety And Pv, Zogenix

Anupam Agarwal | Vice President Global Head Of Drug Safety And Pv | Zogenix » speaking at Drug Safety Congress

Omar Aimer, Pharmacovigilance specialist, Brunel-Sanofi

Omar Aimer | Pharmacovigilance specialist | Brunel-Sanofi » speaking at Drug Safety Congress

Saeed Amin, Managing Director, NHT

Saeed Amin | Managing Director | NHT » speaking at Drug Safety Congress

Julia Appelskog, Head Of Pv Strategy, Merck Group

Julia Appelskog | Head Of Pv Strategy | Merck Group » speaking at Drug Safety Congress

Felix Arellano, Global Head Safety Risk Management, F.Hoffmann-La Roche

Deepa Arora, Independent

Elizabeth Baker, Pharmaceutical Policy Program Director, Physicians Committee for Responsible Medicine

Nicole Baker, Independent

Mate Balazs, Country Head – Patient Safety – Hungary National QPPV – Hungary, Novartis Pharma AG

Mate Balazs | Country Head – Patient Safety – Hungary National QPPV – Hungary | Novartis Pharma AG » speaking at Drug Safety Congress

Steven Beales, SVP, Scientific and Regulatory, WCG Clinical

Steven Beales | SVP, Scientific and Regulatory | WCG Clinical » speaking at Drug Safety Congress

Rachna Bedi, Senior Lead Renal Pharmacist, Imperial College London

Rachna Bedi | Senior Lead Renal Pharmacist | Imperial College London » speaking at Drug Safety Congress

Scott Beebe, Director of Product Strategy, Wolters Kluwer

Scott Beebe | Director of Product Strategy | Wolters Kluwer » speaking at Drug Safety Congress

Albert Befki, Head of Global PV Operations, Gedeon Richter Plc

Albert Befki | Head of Global PV Operations | Gedeon Richter Plc » speaking at Drug Safety Congress

Arvind Bellur, Senior Director, Head Of Safety Data Management, Sanofi

Arvind Bellur | Senior Director, Head Of Safety Data Management | Sanofi » speaking at Drug Safety Congress

Pankaj Bhardwaj, Deputy Manager- Medico Marketing & Pharmacovigilance (International Business), Cadila Pharmaceuticals

Pankaj Bhardwaj | Deputy Manager- Medico Marketing & Pharmacovigilance (International Business) | Cadila Pharmaceuticals » speaking at Drug Safety Congress

Raj Bhogal, Regulatory Inspection Lead, Safety And International, R&D Quality Assurance And Compliance, Takeda Pharmaceuticals

Matthias Boedding, Head Global Drug Safety Medicine, Merck Group

Matthias Boedding | Head Global Drug Safety Medicine | Merck Group » speaking at Drug Safety Congress

Mariette Boerstoel-Streefland, Senior Vice President Of Pharmacovigilance And Drug Safety, Alexion Pharmaceuticals

Mariette Boerstoel-Streefland | Senior Vice President Of Pharmacovigilance And Drug Safety | Alexion Pharmaceuticals » speaking at Drug Safety Congress

Christelle Boeynaems, Multi Country Safety Lead Benelux, Sanofi

Christelle Boeynaems | Multi Country Safety Lead Benelux | Sanofi » speaking at Drug Safety Congress

Tracey Boone, Director, Business Technology - Case Processing Center Of Expertise Rsi Officer, AbbVie

Amanda Bowles, Specialist Leader, Deloitte Consulting LLP

Amanda Bowles | Specialist Leader | Deloitte Consulting LLP » speaking at Drug Safety Congress

Glenn Carroll, Principal, Deloitte Consulting LLP

Glenn Carroll | Principal | Deloitte Consulting LLP » speaking at Drug Safety Congress

Patrick Caubel, Senior Vice President, Pharmacovigilance, Pfizer

Patrick Caubel | Senior Vice President, Pharmacovigilance | Pfizer » speaking at Drug Safety Congress

Scott Chandler, Vice President And Global Head Licensing And Early Development (Lead) Safety, F. Hoffmann - La Roche

Scott Chandler | Vice President And Global Head Licensing And Early Development (Lead) Safety | F. Hoffmann - La Roche » speaking at Drug Safety Congress

Rosalee Chingara, Director-Business Development & Project Management, Sophos IT Services

Rosalee Chingara | Director-Business Development & Project Management | Sophos IT Services » speaking at Drug Safety Congress

David Chonzi, Vice President, Head Of Pharmacovigilance And Epidemiology ( Pve), Allogene Therapeutics

Rishi Chopra, Senior Director, Head of International Pharmacovigilance (IPV), Deputy EU QPPV, GSRS, Biogen

Rishi Chopra | Senior Director, Head of International Pharmacovigilance (IPV), Deputy EU QPPV,  GSRS | Biogen » speaking at Drug Safety Congress

Salvatore Giorgio Cicirello, Senior Director Pharmacovigilance Innovation, Global Drug Safety And Risk Management, Celgene

Salvatore Giorgio Cicirello | Senior Director Pharmacovigilance Innovation, Global Drug Safety And Risk Management | Celgene » speaking at Drug Safety Congress

Mircea Ciuca, Global Therapeutic Area Head Of Global Clinical Safety And Pharmacovigilance, CSL Behring

Mircea Ciuca | Global Therapeutic Area Head Of Global Clinical Safety And Pharmacovigilance | CSL Behring » speaking at Drug Safety Congress

Elizabeth Ciyou Allee, Senior Director, AbbVie

Elizabeth Ciyou Allee | Senior Director | AbbVie » speaking at Drug Safety Congress

Margherita D'Antuono, E.U. Q.P.P.V., Italfarmaco S.P.A.

April Davis, Global Pharmacovigilance Industry Director, Accenture

April Davis | Global Pharmacovigilance Industry Director | Accenture » speaking at Drug Safety Congress

Carola Gómez De La Bárcena, QPPV, Laboratorios Farmaceuticos Rovi

Carola Gómez De La Bárcena | QPPV | Laboratorios Farmaceuticos Rovi » speaking at Drug Safety Congress

Carola Gómez De La Bárcena, QPPV, Laboratorios Farmaceuticos Rovi

Carola Gómez De La Bárcena | QPPV | Laboratorios Farmaceuticos Rovi » speaking at Drug Safety Congress

Carlos De Pablos Martinez, Local Qualified Person Responsible For Pharmacovigilance (Lqppv), Grifols

Carlos De Pablos Martinez | Local Qualified Person Responsible For Pharmacovigilance (Lqppv) | Grifols » speaking at Drug Safety Congress

Peter De Veene, Qppv, Alexion Pharmaceuticals

Peter De Veene | Qppv | Alexion Pharmaceuticals » speaking at Drug Safety Congress

Wivina De Waele, Regional Drug Safety Office, Alexion Pharmaceuticals

Wivina De Waele | Regional Drug Safety Office | Alexion Pharmaceuticals » speaking at Drug Safety Congress

Moin Don, Chief Executive Officer And Founder, P.V.C.O.N. Pharmacovigilance Auditing and Consulting Services

Moin Don | Chief Executive Officer And Founder | P.V.C.O.N. Pharmacovigilance Auditing and Consulting Services » speaking at Drug Safety Congress

Marjan Dzeparoski, Ra & Pv, Bionika Pharmaceuticals

Philip Eichorn, senior director, Pfizer Ltd

Maritess Esguerra, Principal Pharmacovigilance Process Leader, Genentech

Nadia Espanol, Senior Global Drug Safety Specialist, mAbxience

Philippa Evans, Safety Medical Writer, Novo Nordisk

Philippa Evans | Safety Medical Writer | Novo Nordisk » speaking at Drug Safety Congress

Timo Faltus, Research Associate, Pi, Martin-Luther-University Halle-Wittenberg, Germany

Santiago Garnica Velandia, Drug Safety Coordinator, VITALIS SACI

Stewart Geary, Senior Vice President, Chief Medical Officer, Director, Corporate Medical Affairs Headquarters, Eisai

Essam Ghanem, Head Of Drug Safety And Pharmacovigilance (Dspv), Vigi-Care

Trevor Gibbs, Chief Scientific Officer & Co-Founder, MyMedsandMe

Lykke Bjerglund Graff, Head Of Global Safety, LEO Pharma

Lykke Bjerglund Graff | Head Of Global Safety | LEO Pharma » speaking at Drug Safety Congress

Liana Gross Martirosyan, Alternate Prac Member, Netherlands

Liana Gross Martirosyan | Alternate Prac Member | Netherlands » speaking at Drug Safety Congress

Uwe Gudat, Head Of Clinical Safety And Pharmacovigilance Clinical Safety And Pharmacovigilance, Fresenius Kabi

Uwe Gudat | Head Of Clinical Safety And Pharmacovigilance Clinical Safety And Pharmacovigilance | Fresenius Kabi » speaking at Drug Safety Congress

Jefferson Guillon, Pharmacovigilance Manager And Eea Qppv, Seqirus

Jefferson Guillon | Pharmacovigilance Manager And Eea Qppv | Seqirus » speaking at Drug Safety Congress

Israel Gutierrez, Vice President Pharmacovigilance And Drug Safety, Geron Corporation

Israel Gutierrez | Vice President Pharmacovigilance And Drug Safety | Geron Corporation » speaking at Drug Safety Congress

Marqus Hamwright, Senior Director, Argenx

Marqus Hamwright | Senior Director | Argenx » speaking at Drug Safety Congress

Fabian Heisig, Head Of Safety, Benefit Risk And Global Drug Safety, Grunenthal

Fabian Heisig | Head Of Safety, Benefit Risk And Global Drug Safety | Grunenthal » speaking at Drug Safety Congress

wendy Huisman, Managing Director, Vigifit

wendy Huisman | Managing Director | Vigifit » speaking at Drug Safety Congress

Ashish Jain, Associate Director, Syros Pharmaceuticals

Ashish Jain | Associate Director | Syros Pharmaceuticals » speaking at Drug Safety Congress

Rotimi Jaiyesimi, Associate Medical Director For Patient Safety, Basildon University Hospital NHS Foundation Trust

Rotimi Jaiyesimi | Associate Medical Director For Patient Safety | Basildon University Hospital NHS Foundation Trust » speaking at Drug Safety Congress

Sheila Khawaja, Vice Chair, WAPO Association

Sheila Khawaja | Vice Chair | WAPO Association » speaking at Drug Safety Congress

Mariska Kooijmans-Coutinho, Head Of Pharmacovigilance International And Eu Qpp, Amicus Therapeutics U.K. Ltd

Sergiy Kryvych, Drug Safety Officer, Pfizer

Sergiy Kryvych | Drug Safety Officer | Pfizer » speaking at Drug Safety Congress

Manni Kuthiala, Pv Affiliate Strategic Alliance Manager, Roche

Manni Kuthiala | Pv Affiliate Strategic Alliance Manager | Roche » speaking at Drug Safety Congress

Pedro Lima, Regions Medical Safety Head, Sanofi

Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway

Steinar Madsen | Medical Director | Norwegian Medicines Agency, Norway » speaking at Drug Safety Congress

Valentina Mancini, Director Pharmacovigilance/ Eu Qppv, Shionogi Inc

Valentina Mancini | Director Pharmacovigilance/ Eu Qppv | Shionogi Inc » speaking at Drug Safety Congress

Monika Manske, Associate Director Of Global Pharmacovigilance Governance, Mylan

Muriel Marks - De Korver, Executive Director, WAPO Association

Muriel Marks - De Korver | Executive Director | WAPO Association » speaking at Drug Safety Congress

Rie Matsui, Director, Regional Labeling Head Of Asia, Pfizer

Jorgen Matz, Head Of Global Pharmacovigilance And Drug Safety, Insud Pharma

Jorgen Matz | Head Of Global Pharmacovigilance And Drug Safety | Insud Pharma » speaking at Drug Safety Congress

Andrea Maulwurf, Head Of Pharmacovigilance, Eu-Qppv, Allergy Therapeutics

Andrea Maulwurf | Head Of Pharmacovigilance, Eu-Qppv | Allergy Therapeutics » speaking at Drug Safety Congress

Adrian Maynier, Project Lead, UCB

Adrian Maynier | Project Lead | UCB » speaking at Drug Safety Congress

Steven Mcmahon, Director, Irish Patient Association

Steven Mcmahon | Director | Irish Patient Association » speaking at Drug Safety Congress

Adi Meister, Safety Strategy, Teva Pharmaceuticals

Adi Meister | Safety Strategy | Teva Pharmaceuticals » speaking at Drug Safety Congress

Tarik Messaoud, Drug Safety Specialist Pharmacovigilance Specialist, Merck

Tarik Messaoud | Drug Safety Specialist Pharmacovigilance Specialist | Merck » speaking at Drug Safety Congress

Tarrik Messaoud, Independant

Sutirtha Mukhopadhyay, Global Safety Officer, Sanofi

Muhammad Ashar Naeem, Global Director Pharmacovigilance And Medical Affair, Jamjoom Pharma

Muhammad  Ashar Naeem | Global Director Pharmacovigilance And Medical Affair | Jamjoom Pharma » speaking at Drug Safety Congress

Jaylaxmi Nalawade, Associate Director, Lupin Ltd

Jaylaxmi Nalawade | Associate Director | Lupin Ltd » speaking at Drug Safety Congress

Dave Nestor, Director, Deloitte

Andrew Olaharski, Senior Director And Head Of Toxicology, K.S.Q. Therapeutics

Andrew Olaharski | Senior Director And Head Of Toxicology | K.S.Q. Therapeutics » speaking at Drug Safety Congress

Esther Onolememen, Chief Executive Officer And Founder, Sickle Cell Society Ireland

Esther Onolememen | Chief Executive Officer And Founder | Sickle Cell Society Ireland » speaking at Drug Safety Congress

Nneka Onwudiwe, Founder And Chief Executive Officer, Pharmaceutical Economics Consultants of America (PECA) LLC

Nneka Onwudiwe | Founder And Chief Executive Officer | Pharmaceutical Economics Consultants of America (PECA) LLC » speaking at Drug Safety Congress

Bruce Palsulich, Vice President Product Strategy, Oracle Health Sciences

Dr Raphael Pareschi, Pharmacovigilance Associate Director, Pv Country Lead Deputy, Merck

Vladimir Penkrat, Associate Vice President, Indegene

Vladimir Penkrat | Associate Vice President | Indegene » speaking at Drug Safety Congress

Tanja Peters, Deputy Eu-Qppv, Head Pv Intelligence, Boehringer Ingelheim Pharma GmbH & Co. KG

Anastasia Philippova, Qppv, Geropharm

Mary Lynne Van Poelgeest-Pomfret, President, President of the World Federation for Incontinence and Pelvic Pain - WFIP

Vivek Poojary, Senior Manager Pharmacovigilance, Alkem Laboratories Limited

Vivek Poojary | Senior Manager Pharmacovigilance | Alkem Laboratories Limited » speaking at Drug Safety Congress

John Poustie, Senior Director, Qppv Global Pharmacovigilance, Norgine Ltd

John Poustie | Senior Director, Qppv Global Pharmacovigilance | Norgine Ltd » speaking at Drug Safety Congress

Nicolas Praet, Senior Epidemiologist Director, GlaxoSmithKline

Nicolas Praet | Senior Epidemiologist Director | GlaxoSmithKline » speaking at Drug Safety Congress

Elena Prokofyeva, Head Of Drug Safety Unit, Department Of R&D, A.F.M.P.S

Elena Prokofyeva | Head Of Drug Safety Unit, Department Of R&D | A.F.M.P.S » speaking at Drug Safety Congress

Rohit Pushparajan, R&D Operations Lead Europe, Accenture

Rohit Pushparajan | R&D Operations Lead Europe | Accenture » speaking at Drug Safety Congress

Rohit Pushparajan, R&D Operations Lead Europe, Accenture

Rohit Pushparajan | R&D Operations Lead Europe | Accenture » speaking at Drug Safety Congress

Nawab Qizilbash, Senior Clinical Epidemiologist (Honorary Associate Professor, London School of Hygiene and Tropical Medicine), Oxon Epidemiology

Nawab Qizilbash | Senior Clinical Epidemiologist (Honorary Associate Professor, London School of Hygiene and Tropical Medicine) | Oxon Epidemiology » speaking at Drug Safety Congress

Nibedita Rath, Scientific Director, Open Source Pharma Foundation

Nibedita Rath | Scientific Director | Open Source Pharma Foundation » speaking at Drug Safety Congress

Susanne Reymann, Head Pv Quality Systems And Compliance, Abbott Laboratories GmbH

Susanne Reymann | Head Pv Quality Systems And Compliance | Abbott Laboratories GmbH » speaking at Drug Safety Congress

Jackie Roberts, Executive Director - Regulatory, Pharmacovigilance And Medical, Accord Healthcare

Jackie Roberts | Executive Director - Regulatory, Pharmacovigilance And Medical | Accord Healthcare » speaking at Drug Safety Congress

Angela Caro Rojas, President, Colombian Pharmacovigilance Association

Angela Caro Rojas | President | Colombian Pharmacovigilance Association » speaking at Drug Safety Congress

Marco Sardella, Chief Pharmacovigilance Officer And Q.P.P.V. For Europe, Adienne

Marcus Schartau, Safety Surveillance Risk Management Specialist, Safety Surveillance, Novo Nordisk A/S

Marcus Schartau | Safety Surveillance Risk Management Specialist, Safety Surveillance | Novo Nordisk A/S » speaking at Drug Safety Congress

Rudi Scheerlinck, Global Head Pharmacovigilance Risk Management, Nestle Skin Health

Rudi Scheerlinck | Global Head Pharmacovigilance Risk Management | Nestle Skin Health » speaking at Drug Safety Congress

Hildia Schreuder, Country Safety Lead, Sanofi

Hildia Schreuder | Country Safety Lead | Sanofi » speaking at Drug Safety Congress

Vipin Sethi, Head – Global Pharmacovigilance and Medical Affairs, Cadila Pharmaceuticals

Vipin Sethi | Head – Global Pharmacovigilance and Medical Affairs | Cadila Pharmaceuticals » speaking at Drug Safety Congress

Akhilesh Sharma, President and Chief Medical Officer, Alkem Laboratories Ltd

Akhilesh Sharma | President and Chief Medical Officer | Alkem Laboratories Ltd » speaking at Drug Safety Congress

Grishma Sharma, Managing Director, Accenture

Grishma Sharma | Managing Director | Accenture » speaking at Drug Safety Congress

Priya Singhal, Head of Research & Development, Zafgen, Inc.

Priya Singhal | Head of Research & Development | Zafgen, Inc. » speaking at Drug Safety Congress

Howard Snow, Howard Snow, Head Patient Safety, Sandoz Biopharmaceuticals, Chief Medical Office And Patient Safety, Novartis International AG

Howard Snow | Howard Snow, Head Patient Safety, Sandoz Biopharmaceuticals, Chief Medical Office And Patient Safety | Novartis International AG » speaking at Drug Safety Congress

Katrien Soleme, Head Of Global Quality Regulatory Compliance And Clinical Trials And Safety, Bristol Myers Squibb

Katrien Soleme | Head Of Global Quality Regulatory Compliance And Clinical Trials And Safety | Bristol Myers Squibb » speaking at Drug Safety Congress

John Solomon, Head Of Pharmacovigilance, Sanofi

John Solomon | Head Of Pharmacovigilance | Sanofi » speaking at Drug Safety Congress

Anna Sommerville, Accenture

Anna Sommerville |  | Accenture » speaking at Drug Safety Congress

Natalie Springveld, Global Safety Leader, Bayer Basel

Natalie Springveld | Global Safety Leader | Bayer Basel » speaking at Drug Safety Congress

Doris Stenver, Former Chief Medical Officer, Member Of Prac At Ema, Danish Medicines Agency

Doris Stenver | Former Chief Medical Officer, Member Of Prac At Ema | Danish Medicines Agency » speaking at Drug Safety Congress

Marina Suvakov, Director, Compliance And Business Management, Otsuka Europe Development and Commercialisation Ltd

Marina Suvakov | Director, Compliance And Business Management | Otsuka Europe Development and Commercialisation Ltd » speaking at Drug Safety Congress

Qi Tang, Associate Director Of Digital and Data Sciences, Sanofi

Qi Tang | Associate Director Of Digital and Data Sciences | Sanofi » speaking at Drug Safety Congress

Nasim Tavakoli, Group Drug Safety Manager - Operations, F. Hoffmann-La Roche Ltd

Nasim Tavakoli | Group Drug Safety Manager - Operations | F. Hoffmann-La Roche Ltd » speaking at Drug Safety Congress

Maria Tello, Head Of Safety, Rakuten Medical

Maria Tello | Head Of Safety | Rakuten Medical » speaking at Drug Safety Congress

Francesco Tescione, Eu Qualified Person For Pharmacovigilance Qppv, Molteni Farmaceutici

Sivakumar Thiagarajan, VP and Head of R&D, Indegene

Shani Thilak, Senior Manager - Advisory, Kinapse Ltd

Shani Thilak | Senior Manager - Advisory | Kinapse Ltd » speaking at Drug Safety Congress

Ricarda Tiemeyer, Head Of Drug Safety, Biogen

Klaudia Traudtner, Head of Pharmacovigilance and Safety, Kiadis Pharma

Klaudia Traudtner | Head of Pharmacovigilance and Safety | Kiadis Pharma » speaking at Drug Safety Congress

Phil Tregunno, Signal Management Unit Manager, And Imi Web-Radr Project Lead, Medicines & Healthcare Products Regulatory Agency

Shinobu Uzu, Associate Executive Director, Pharmaceuticals and Medical Devices Agency

Shinobu Uzu | Associate Executive Director | Pharmaceuticals and Medical Devices Agency » speaking at Drug Safety Congress

Lionel Van Holle, Safety Surveillance Lead, UCB

Lionel Van Holle | Safety Surveillance Lead | UCB » speaking at Drug Safety Congress

Bert Van Leeuwen, Deputy Qppv, Astellas Pharma Europe BV

Bert Van Leeuwen | Deputy Qppv | Astellas Pharma Europe BV » speaking at Drug Safety Congress

Dennis Vargo, Vice President, Head of Drug Safety and Pharmacovigilance, Akebia Therapeutics , Inc.

Dennis Vargo | Vice President, Head of Drug Safety and Pharmacovigilance | Akebia Therapeutics , Inc. » speaking at Drug Safety Congress

Ale Maria Vazquez-Gragg, Vice President Of Global Patient Safety, Argenx

Ale Maria Vazquez-Gragg | Vice President Of Global Patient Safety | Argenx » speaking at Drug Safety Congress

Archi Wani, Principal Map Vendor Compliance Lead Us Drug Safety, Market Research And Patient Support Programs, Genentech

Archi Wani | Principal Map Vendor Compliance Lead Us Drug Safety, Market Research And Patient Support Programs | Genentech » speaking at Drug Safety Congress

Hal Ward, Director Of Executive Drug Safety Surveillance, Kyowa Hakko Kirin Co Ltd

Aman Wasan, Vice President, Global Pv and Global Client Partners, ArisGlobal

Heinz Weidenthaler, Director Pharmacovigilance, Qppv, Bavarian Nordic

James Whitehead, Principal, Astra Zeneca

James Whitehead | Principal | Astra Zeneca » speaking at Drug Safety Congress

Songlin Xue, Executive Vice President And Global Head Of Pharmacovigilance, Astellas Pharma

Songlin Xue | Executive Vice President And Global Head Of Pharmacovigilance | Astellas Pharma » speaking at Drug Safety Congress

Syed Zaferuddin, Deputy Qppv+ Pharmacovigilance And Clinical Trial Manager, Julphar

Syed Zaferuddin | Deputy Qppv+ Pharmacovigilance And Clinical Trial Manager | Julphar » speaking at Drug Safety Congress

 

APPLY TO SPEAK

 

Get Involved At World Drug Safety Congress

 

To Sponsor Or Exhibit


Edmond Rama
edmond.rama@terrapinn.com
+44 20 7092 1052

 

 

 

To Speak


Anastasia Beretsos
anastasia.beretsos@terrapinn.com
+44 20 7092 1070

 

 

 

To Register


Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210